Condition
Recurrent Gliosarcoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Recurrent Gliosarcoma clinical trials that are recruiting, in United States. By phase: Phase 1 (3), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest Recurrent Gliosarcoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| GI-102 With or Without Pembrolizumab Before Surgery for Recurrent or Progressive Grade 4 Gliomas | Phase 2 | Rochester, Minnesota | Recruiting | Dec 24, 2025 |
| ERAS-801 for operable or recurrent EGFR-altered IDH-wildtype Grade IV glioblastoma or astrocytoma | Phase 1 | Los Angeles, California and 1 other locations | Recruiting | Jul 28, 2025 |
| Engineered NK cells for treating recurrent glioblastoma | Phase 1 | Houston, Texas | Recruiting | Aug 5, 2021 |
| Using a modified cold virus to treat recurrent high-grade brain tumors | Phase 1 | Houston, Texas | Recruiting | Apr 1, 2019 |
All recruiting trials (4)
-
GI-102 With or Without Pembrolizumab Before Surgery for Recurrent or Progressive Grade 4 Gliomas
The team will test whether giving GI-102 alone or together with pembrolizumab before surgery helps adults with recurrent or progressive IDH‑wildtype glioblastoma or IDH‑mutant grade 4 astrocytoma.
-
ERAS-801 for operable or recurrent EGFR-altered IDH-wildtype Grade IV glioblastoma or astrocytoma
This trial tests ERAS-801, a brain-penetrant EGFR blocker, to see if it is safe and changes tumor metabolism in adults with resectable or recurrent IDH-wildtype Grade IV glioblastoma or astrocytoma that have EGFR amplification or mutation.
-
Engineered NK cells for treating recurrent glioblastoma
This study is testing a new type of immune cell treatment for people with recurrent glioblastoma to see if it's safe and how well it works against the tumor.
-
Using a modified cold virus to treat recurrent high-grade brain tumors
This study is testing a new treatment using a modified cold virus delivered through special stem cells to see if it can safely help people with recurring high-grade brain tumors like glioblastoma.
Related topics
Quick answers
How many Recurrent Gliosarcoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.